Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway. The gene discussed is AKT1; the disease is hereditary clear cell renal cell carcinoma.